Absolutely not- this scenario is a perfect one to outline that most patients need to remain at the highest tolerated dose in order to maintain their weight loss long-term
Specifically: Adults with a BMI of 30 or above (classified as obese) Adults with a BMI of 27 or above (overweight) who also have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, high cholesterol, or cardiovascular disease These are the same eligibility criteria as the Wegovy injection
This science-backed formula is designed to support healthy blood sugar levels and regulate appetite, making it a perfect complement to a fiber- and protein-rich diet
Paris 6 , 297333 (1886)
Amreen Sitabkhan of U.S
contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Risk of diabetic retinopathy complications in patients with pre-existing retinopathy Potential for acute kidney injury, particularly related to dehydration Caution or avoidance in severe gastroparesis or severe gastrointestinal disease Suicidality warning for weight-management indications (Wegovy, Saxenda) Potential for altered absorption of oral medications due to delayed gastric emptying In older adults with cognitive impairment, medication adherence may be challenging, and gastrointestinal side effects could lead to dehydration or nutritional deficiencies